Grant-Huerta Yanina
Atara Biotherapeutics, Inc. · Chief Accounting Officer
Grant-Huerta Yanina is listed in filings as Chief Accounting Officer at Atara Biotherapeutics, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Atara Biotherapeutics, Inc. (ATRA). The current snapshot covers public activity from May 20, 2025 to May 20, 2026. Reported amounts are shown as $22.0K to $508. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $1.9k377 shares | SellMar 2, 2026 | $5.08 | $8.39 | |
| $508100 shares | SellMar 2, 2026 | $5.08 | $8.39 | |
| $12224 shares | SellMar 2, 2026 | $5.08 | $8.39 | |
| $8.1k1.6k shares | SellMar 2, 2026 | $5.08 | $8.39 | |
| $1.1k85 shares | SellNov 17, 2025 | $13.19 | $8.39 | |
| $97674 shares | SellNov 17, 2025 | $13.19 | $8.39 | |
| $22k1.6k shares | SellNov 17, 2025 | $13.19 | $8.39 | |
| $99986 shares | SellAug 18, 2025 | $11.61 | $8.39 | |
| $63855 shares | SellAug 18, 2025 | $11.61 | $8.39 | |
| $19k1.7k shares | SellAug 18, 2025 | $11.61 | $8.39 | |
| $15k2.2k shares | SellMay 16, 2025 | $6.76 | $8.39 |